Clinical Trials · NCT04296149

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
European Institute of Oncology
Enrollment
5
Start date
Feb 2017
Locations
1 site, Italy
Primary endpoint
Evaluation of sensitivity of a beta- probe
View Octreotide compound reference